Elkan R. Gamzu
Chairman at NeuroHealing Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Neal M. Farber | M | - |
NeuroHealing Pharmaceuticals, Inc.
 NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | - |
| David I. Gwynne | M | - |
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | 40 years |
| Mark Leuchtenberger | M | 67 |
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | 11 years |
| Joshua D. Hamermesh | M | 51 |
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sydney Colin Neill | M | 77 | 6 years | |
| James A. Meer | M | 78 | 2 years | |
| Gadi Riesenfeld | M | 79 | 13 years | |
| Simcha Sadan | M | 82 |
The Hebrew University of Jerusalem
| 5 years |
| Elon Kohlberg | M | 78 |
The Hebrew University of Jerusalem
| 5 years |
| Srini Akkaraju Akkaraju | M | 56 | 5 years | |
| Alan Rubino | M | 69 | 2 years | |
| Galia Maor | M | 81 |
The Hebrew University of Jerusalem
| 2 years |
| Eitan Raff | M | 82 |
The Hebrew University of Jerusalem
| 6 years |
| Bob Cook | M | 68 | 6 years | |
| Micha Shkedi | M | 84 |
The Hebrew University of Jerusalem
| 5 years |
| Ester Levanon | F | 78 |
The Hebrew University of Jerusalem
| 5 years |
| Zvi Ioav Cabantchik | M | - |
The Hebrew University of Jerusalem
| 5 years |
| Dan Shochat | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Anthony Evnin | M | 83 | 6 years | |
| Charles Newhall | M | 78 | 6 years | |
| Haim Benyamini | M | 85 |
The Hebrew University of Jerusalem
| - |
| Barbara A. Kane-Burke | F | - | 3 years | |
| Ephraim Abramson | M | 77 |
The Hebrew University of Jerusalem
| 3 years |
| Yehuda Levy | M | 79 |
The Hebrew University of Jerusalem
| 4 years |
| Raymond E. McKee | M | - | 6 years | |
| Izhak Zisman | M | 86 |
The Hebrew University of Jerusalem
| 3 years |
| Yaacov Shoham | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Uzi Karniel | M | - |
The Hebrew University of Jerusalem
| 3 years |
| Leora Meridor | M | 76 |
The Hebrew University of Jerusalem
| 4 years |
| David Cahen | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Rami Avraham Guzman | M | 85 |
The Hebrew University of Jerusalem
| 4 years |
| Flavio Grynszpan | M | - | - | |
| Ory Slonim | M | 80 |
The Hebrew University of Jerusalem
| 3 years |
| David Kolitz | M | 81 |
The Hebrew University of Jerusalem
| 4 years |
| Joseph Mizrachi | M | 78 |
The Hebrew University of Jerusalem
| 4 years |
| Ben-Zion Weiner | M | 80 |
The Hebrew University of Jerusalem
| 4 years |
| Lawrence F. Marshall | M | 80 | - | |
| Mony Ben Dor | M | 78 | 11 years | |
| Alon Michal | M | - | - | |
| Dan Suesskind | M | 80 |
The Hebrew University of Jerusalem
| 4 years |
| David Schlachet | M | 78 | 14 years | |
| Howard Grossberg | M | - | - | |
| Achim Brandt | M | - |
The Hebrew University of Jerusalem
| 1 years |
| Masoud A. Alikhani | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Dan Falk | M | 79 |
The Hebrew University of Jerusalem
| 4 years |
| Ehud Barak | M | 81 |
The Hebrew University of Jerusalem
| 4 years |
| Yossi Rosen | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Bob Johnston | M | 87 | 4 years | |
| Steven M. Leventer | M | 68 | - | |
| Iris Alroy | M | - | - | |
| Abraham Sartani | M | 76 | 3 years | |
| Yehudit Bronicki | M | 82 |
The Hebrew University of Jerusalem
| 4 years |
| Zeev Holtzman | M | 82 |
The Hebrew University of Jerusalem
| 5 years |
| Asher Tishler | M | 77 |
The Hebrew University of Jerusalem
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 30 | 55.56% |
| United States | 24 | 44.44% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elkan R. Gamzu
- Personal Network
